دانلود Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score Assay

ترجمه فارسی Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score Assay
قیمت : 330,000 ریال
شناسه محصول : 2009257
نویسنده/ناشر/نام مجله : EJSO the journal of cancer surgery
سال انتشار: 2017
تعداد صفحات انگليسي : 10
نوع فایل های ضمیمه : pdf+word
حجم فایل : 618 Kb
کلمه عبور همه فایلها : www.daneshgahi.com
عنوان انگليسي : Prognostic and predictive indicators in early-stage breast cancer and the role of genomic profiling: Focus on the Oncotype DX® Breast Recurrence Score Assay

چکیده

Abstract

Although useful prognostic and predictive insights can be gained from patient and tumour characteristics in early-stage breast cancer, it is not always straightforward to predict the likely risk of recurrence for each individual patient following breast surgery. One of the most difficult challenges faced by clinicians is identifying patients who may benefit most from adjuvant chemotherapy, and distinguishing these cases from those where endocrine therapy may be sufficient for cure. Genomic tests such as the Oncotype DX® Breast Recurrence Score® Assay have been developed to provide a robust and clinically validated assessment of a patient's individual tumour signature. The Oncotype DX Assay is included in treatment guidelines for estimating both the risk of distant recurrence and predicting adjuvant chemotherapy benefit for early-stage breast cancer patients with human epidermal growth factor receptor 2-negative, oestrogen-receptor positive, and axillary lymph node negative or positive (1–3 positive nodes) disease. In this article, we review unmet needs for prognostication and prediction in early-stage breast cancer, and consider how the information provided by the Recurrence Score is complementary to that gained from the assessment of more traditional clinicopathologic criteria. Routine use of the assay in clinical practice, limitations and possible future directions are also discussed.

 

Keywords: Adjuvant chemotherapy Breast cancer Genomics Personalised medicine
این برای گرایش های: کلیه گرایش ها، کاربرد دارد. همچنین این در گرایش های: کلیه گرایش ها، می تواند کاربرد داشته باشد. [ برچسب: ]

Skip Navigation Links